Blockchain Registration Transaction Record

Pacylex to Showcase Breakthrough Cancer Therapies at BIO Convention

Pacylex Pharmaceuticals to present groundbreaking NMT inhibitors for cancer at BIO Convention, offering new hope for hematologic and solid tumor treatments.

Pacylex to Showcase Breakthrough Cancer Therapies at BIO Convention

This news is significant as it highlights Pacylex Pharmaceuticals' innovative approach to cancer treatment, focusing on NMTis that target critical cancer processes. The development of oral zelenirstat and NMTis as ADC payloads could revolutionize the treatment of hematologic and solid tumor cancers, offering hope to patients with limited options. The company's participation in the BIO Convention underscores the potential for partnerships that could accelerate the availability of these therapies, marking a critical step forward in oncology research and patient care.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x1e30aa2151d97e2cf88469832bc826014ca73170c5c7bb7b8503032a926fca01
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintfaceAY8m-4b76b20f298a6cb648cd26a6a40e3479